Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141491 |
| CAS No | NA |
| Mol.F. | C12H13ClN2O |
| Mol.Wt. | 236.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141492 |
| CAS No | NA |
| Mol.F. | C12H13ClN2O |
| Mol.Wt. | 236.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141493 |
| CAS No | NA |
| Mol.F. | C20H19N5O3 |
| Mol.Wt. | 377.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141494 |
| CAS No | NA |
| Mol.F. | C34H26Cl2N8O3 |
| Mol.Wt. | 665.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141495 |
| CAS No | NA |
| Mol.F. | C17H14ClN5O2 |
| Mol.Wt. | 355.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141496 |
| CAS No | NA |
| Mol.F. | C21H19N3O9 |
| Mol.Wt. | 457.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141497 |
| CAS No | NA |
| Mol.F. | C21H21N3O10 |
| Mol.Wt. | 475.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141498 |
| CAS No | NA |
| Mol.F. | C22H22N2O9 |
| Mol.Wt. | 458.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141499 |
| CAS No | NA |
| Mol.F. | C16H14ClN7O4 |
| Mol.Wt. | 403.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141500 |
| CAS No | NA |
| Mol.F. | C19H28ClN3O11 |
| Mol.Wt. | 509.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141501 |
| CAS No | NA |
| Mol.F. | C16H14ClN7O4 |
| Mol.Wt. | 403.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141502 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O4 |
| Mol.Wt. | 334.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141503 |
| CAS No | NA |
| Mol.F. | C15H20N4O2 |
| Mol.Wt. | 288.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141504 |
| CAS No | NA |
| Mol.F. | C16H16N2O5 |
| Mol.Wt. | 316.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141505 |
| CAS No | NA |
| Mol.F. | C21H23N3O3S |
| Mol.Wt. | 397.5 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N0141506 |
| CAS No | NA |
| Mol.F. | C22H23N3O3S |
| Mol.Wt. | 409.5 |
| INV STATUS | CUSTOM SYNTHESIS |